emerging glp-1 gip obesity treatments 2025 Transforming obesity: The advancement of multi-receptor drugs: Cell Obesity GLP-1 Market

GLP-1 medications are large peptides that do not readily cross skin

Advances in Clinical Cardiology 2017: A Summary of Key Clinical Trials

Among them, -3 polyunsaturated fatty acids and polyphenols are important components of anti-inflammatory diets, while collagen peptides, vitamin D, calcium, probiotics, glucosamine, chondroitin and hyaluronic acid are commonly used in clinical practice as important nutritional support treatments or preventive measures for OA to promote cartilage repair

It also supports the composition and activity of the gut microbiome, promoting an increase in beneficial bacteria and the production of short-chain fatty acids